MACMILLAN, MUIR & ASSOCIATES DEFINING THE FIELD OF BRAIN MEDICINE EST. 2026
MacMillan, Muir & Associates

RESEARCH

Evidence in practice.

Evidence generation, outcomes and scientific partnerships. We run trials inside working clinics, contribute to the post-marketing registries that move payer policy, and publish on what we measure.

ALL WAYS TO ENGAGE

ROLES

How we work with sponsors and investigators.

  • Co-authors of the SWIFT trial, the multisite randomized non-inferiority trial of accelerated deep TMS for depression, and its 12-month durability and patient-reported-outcome follow-ups
  • Site investigators for Magnus Medical's SAINT open-label study; the only East Coast site
  • Contributors to BrainsWay's post-marketing registries for depression, OCD and adolescent depression, the evidence base behind several national coverage policies
  • NIMH-funded work with iRxReminder on video-based detection of tardive dyskinesia
  • Principal investigator (Owen) for MindMed's study quantifying the processes of psychotherapy at scale
  • First psychometric evaluation of the DSM-5-TR Level 1 Cross-Cutting Symptom Measure in a real-world outpatient sample (Carlene, first author)

SELECTED PUBLICATIONS

Peer-reviewed.

Full lists: Carlene on PubMed · Owen on PubMed.

GET IN TOUCH

Have a research question?

Trials, registries, outcomes analyses and scientific advisory. Tell us the hypothesis and the timeline.

INQUIRE ABOUT RESEARCH